We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01856439
Recruitment Status : Terminated (As a result of termination of development of Prosavin, it is no longer possible for Sio to either commence or to continue any related clinical trials.)
First Posted : May 17, 2013
Last Update Posted : May 3, 2022
Oxford BioMedica
Information provided by (Responsible Party):
Sio Gene Therapies ( Axovant Sciences Ltd. )